Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Faster Visa Endorsement will Support International Mobility for Top Researchers

Published: Monday, April 07, 2014
Last Updated: Monday, April 07, 2014
Bookmark and Share
This visa route is designed for the brightest and best bringing them from outside the European Economic Area to the UK.

The Wellcome Trust and Research Councils UK are collaborating with the Royal Society, the British Academy and the Royal Academy of Engineering to pilot a streamlined endorsement process to make it easier for outstanding international researchers to obtain Tier 1 Exceptional Talent or Exceptional Promise visas.

Under the new process, the Royal Society, British Academy and Royal Academy of Engineering - the three designated ‘competent bodies’ - will guarantee that visa applications from researchers who have been awarded senior- and intermediate-level fellowships and Investigator Awards by the Wellcome Trust will be endorsed. Once endorsed, the researcher can then proceed to stage 2 of the process and apply to the Home Office for the visa.

This visa route is designed for the brightest and best in the fields of natural science, humanities, social sciences, engineering and the arts, bringing them from outside the European Economic Area to the UK, and is open both to those who have already been recognised as world leaders (Exceptional Talent) and to those with the potential to be future leaders (Exceptional Promise) in their fields.

Professor Jeremy Farrar, Director of the Wellcome Trust, said: "If we are to ensure that the UK remains a world leader in biomedical research, we must be able to attract the brightest minds to base their research here. We therefore welcome the introduction of this new process to accelerate the consideration of Tier 1 visa applications from outstanding international researchers who wish to carry out their work in the UK."

Professor Rick Rylance, Chair of Research Councils UK, said: "We welcome the announcement by the Royal Society, British Academy and Royal Academy of Engineering, the Designated Competent Bodies, to pilot a streamlined endorsement process in order to make it easier for outstanding international researchers who have been awarded a Research Councils funded fellowship to obtain a Tier 1 Exceptional Talent visa."

The three competent bodies have written to Vice Chancellors outlining changes to the process that they hope will be in the interests of the science, engineering and humanities community.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

£30 Million Boost for Biomedical Engineering Research
Partnership will provide funding for long-term projects that address healthcare needs.
Wednesday, September 12, 2012
Open Access Drug Discovery Database Launches With Half a Million Compunds
ChEMBLdb, a vast online database of information on the properties and activities of drugs and drug-like small molecules and their targets, launches today with information on over half-a-million compounds.
Monday, January 18, 2010
Engineering Innovative Solutions for 21st Century Medicine
EPSRC announced £41M funding for four new UK Centres of Excellence in Medical Engineering.
Tuesday, June 30, 2009
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!